Can an AI app fix Kids' speech delays? new trial aims to find out
NCT ID NCT07613268
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an AI-based app called HiDongDong can improve speech in children aged 2 to 14 who have trouble pronouncing words. Forty-eight children will either use the app at home for 20 minutes a day, five days a week, or receive standard speech therapy. The goal is to see if the app helps them speak more clearly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HiDongDong application (AI-based language rehabilitation program)
What this could lead to
If it works, this could offer a convenient, at-home digital tool to help children with speech delays improve their articulation without needing constant therapist visits.
What could go wrong
This is a small, early exploratory trial with only 48 participants. The app may not be more effective than standard therapy, and results may not apply to all children with speech disorders.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPEECH SOUND DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••